Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor

Details for Australian Patent Application No. 2004243481 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Norcross, Roger David; Riemer, Claus; Jakob-Roetne, Roland; Flohr, Alexander

Agent Spruson & Ferguson

Pub. Number AU-B-2004243481

PCT Pub. Number WO2004/105755

Priority 03012118.0 30.05.03 EP

Filing date 21 May 2004

Wipo publication date 9 December 2004

Acceptance publication date 9 October 2008

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/5377 (2006.01)

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 417/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/105755 Priority application(s): WO2004/105755

9 October 2008 Application Accepted

  Published as AU-B-2004243481

5 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243487-Macrocyclic quinazoline derivatives as antiproliferative agents

2004243478-Fungicidal mixtures for controlling rice pathogens